Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Deltorphin C (trifluoroacetate salt)

  • Zoom
    Deltorphin C (trifluoro<wbr/>acetate salt)
  • Deltorphin C (trifluoro<wbr/>acetate salt)
Cat No: 30050
Biochemicals - Receptor Pharmacology
Cayman

Deltorphin C is a peptide agonist of δ-opioid receptors (Ki = 0.15 nM) that has been found in Phyllomedusa bicolor.{46876} It is selective for δ-opioid receptors over µ- and ĸ-opioid receptors. It induces δ-opioid receptor translocation from large den...

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • L-tyrosyl-D-alanyl-L-phenylalanyl-L-?-aspartyl-L-valyl-L-valyl-glycinamide, trifluoroacetate salt
Correlated keywords:
  • 122752-15-2 TFA
Product Overview:
Deltorphin C is a peptide agonist of δ-opioid receptors (Ki = 0.15 nM) that has been found in Phyllomedusa bicolor.{46876} It is selective for δ-opioid receptors over µ- and ĸ-opioid receptors. It induces δ-opioid receptor translocation from large dense-core vesicles to the cell surface and induces calcitonin gene-related peptide (CGRP) release in isolated mouse dorsal root ganglion (DRG) cells when used at concentrations of 0.1 and 1 µM, respectively, effects that can be blocked with the δ-opioid receptor antagonist naltrindole (Item No. 9000705).{46877} Intrathecal administration of deltorphin C (0.15, 1.5, and 15 µg/animal) increases latency to withdraw in the paw pressure and tail-flick tests in rats.{46878}
Size 1 mg
Shipping dry ice
Molecular Formula C37H52N8O10 • XCF3COOH
SMILES OC1=CC=C(C[C@H](N)C(N[C@H](C)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(NCC(N)=O)=O)=O)=O)=O)=O)=O)C=C1.OC(C(F)(F)F)=O
Molecular Weight 768,9
Formulation A solid
Purity ≥95%
Custom Code 2924.19
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

Search